VA Sets January 2027 for Adult-Use Cannabis Sales: Last Week in Weed March 9–16, 2026
Virginia adult-use cannabis sales are scheduled to start in January 2027, marking a key regulatory milestone. This change will provide a regulated market that clinicians can reference for patient counseling. The new framework aims to improve product…
Pa. Senate Amends Cannabis Bill with Stricter Pennsylvania Hemp Standards
Pennsylvania hemp standards have been updated to align with stricter federal regulations, enhancing cannabis product safety. These changes reduce contamination risks and improve product consistency for medical cannabis users. Clinicians can now counsel…
Alabama Patients Seek Medical Cannabis Cards as Dispensaries Open
Alabama medical cannabis certification is essential for patients seeking legal access to cannabis treatment. As dispensaries prepare to open, understanding certification requirements is critical. Patients and clinicians must stay informed about Alabama's…
Takeaways from the 2026 South Dakota Legislative Session
The 2026 South Dakota medical marijuana oversight committee has expanded to include diverse professional representation. This change aims to improve governance and clinical application of cannabis policy. Clinicians should monitor these updates to…
Missouri Cannabis Rules Change to Address Microbusiness Fraud
Missouri cannabis microbusiness licensing has been updated to address fraud concerns affecting product safety. These regulatory changes impact clinicians' ability to recommend legitimate cannabis products. Understanding these licensing rules is essential…
Virginia Cannabis Sales Legalization Bill Heads to Governor (Newsletter: March 16, 2026)
Virginia cannabis legalization impact is reshaping healthcare provider practices and patient access. Clinicians must understand regulatory changes affecting cannabis use and safety. This evolving landscape requires updated clinical protocols and patient…
Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch
The marijuana gummies recall Ohio highlights ongoing safety concerns in cannabis edible products. This recall affects multiple retail locations across the state. Clinicians and patients should be aware of quality control issues and monitor product safety…
CED Digest: 230 Items — March 15, 2026
This CED Digest highlights cannabis compounds fatty liver clinical relevance with 230 curated items for clinicians. CBD and CBG show potential therapeutic effects on fatty liver disease. These findings offer evidence-based insights for patient care in…
Oklahoma Bill Proposes Marijuana Tax to Support First Responders
Oklahoma marijuana tax legislation proposes funding first responders through cannabis tax revenue. This bill could affect healthcare infrastructure and cannabis-related public health costs. Clinicians should monitor these changes to support patient care…
Michigan Cannabis Licenses Decline as Industry Shakeout Forces Growers and Dispensaries to Exit
Michigan cannabis industry consolidation is driving a decline in active licenses as growers and dispensaries exit the market. This shakeout affects product availability and patient access. Clinicians should monitor these changes to advise patients…